Detalles de la búsqueda
1.
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
N Engl J Med
; 388(10): 873-887, 2023 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36808186
2.
Does PET-CT Have a Role in the Evaluation of Tuberculosis Treatment in Phase 2 Clinical Trials?
J Infect Dis
; 229(4): 1229-1238, 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37788578
3.
Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis: proof-of-concept, partially-randomised, double-blind, placebo-controlled, dose-escalation trial.
J Infect Dis
; 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38527849
4.
Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.
N Engl J Med
; 385(4): 330-341, 2021 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34289276
5.
Effects of Increasing Concentrations of Rifampicin on Different Mycobacterium tuberculosis Lineages in a Whole-Blood Bactericidal Activity Assay.
Antimicrob Agents Chemother
; 66(2): e0169921, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34871090
6.
Treatment Strategy for Rifampin-Susceptible Tuberculosis. Reply.
N Engl J Med
; 388(24): 2298, 2023 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314717
7.
Gene expression responses to anti-tuberculous drugs in a whole blood model.
BMC Microbiol
; 20(1): 81, 2020 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32264819
8.
A blood RNA transcript signature for TB exposure in household contacts.
BMC Infect Dis
; 20(1): 403, 2020 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32517725
9.
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial.
Clin Infect Dis
; 68(7): 1184-1192, 2019 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30060027
10.
Sub-clinical abnormalities detected by PET/MRI in household tuberculosis contacts.
BMC Infect Dis
; 19(1): 83, 2019 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30678651
11.
Mapping the medical outcomes study HIV health survey (MOS-HIV) to the EuroQoL 5 Dimension (EQ-5D-3 L) utility index.
Health Qual Life Outcomes
; 17(1): 83, 2019 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077251
12.
Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis.
Clin Infect Dis
; 66(12): 1846-1857, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29272346
13.
Coadministration of Allopurinol To Increase Antimycobacterial Efficacy of Pyrazinamide as Evaluated in a Whole-Blood Bactericidal Activity Model.
Antimicrob Agents Chemother
; 61(10)2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28739782
14.
Assessment of second-line antiretroviral regimens for HIV therapy in Africa.
N Engl J Med
; 371(3): 234-47, 2014 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25014688
15.
Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial.
J Antimicrob Chemother
; 72(7): 2012-2019, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28333342
16.
Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial.
Clin Infect Dis
; 63(2): 257-64, 2016 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27143662
17.
A Novel Approach to CT, MR, and PET Examination of Patients with Infections Requiring Stringent Airborne Precautions.
Radiology
; 278(3): 881-7, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26402398
18.
Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial.
J Neurovirol
; 22(1): 104-13, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26323809
19.
A simple and powerful method for the estimation of intervention effects on serological endpoints using paired interval-censored data.
J Biopharm Stat
; 25(1): 124-36, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-24835750
20.
Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT).
EClinicalMedicine
; 69: 102457, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361989